Are you over 18 and want to see adult content?
More Annotations
![A complete backup of armstrongrelocation.com](https://www.archivebay.com/archive5/images/b8a6c9f3-0830-43cc-9d70-89485b356492.png)
A complete backup of armstrongrelocation.com
Are you over 18 and want to see adult content?
![A complete backup of fundacion-canna.es](https://www.archivebay.com/archive5/images/18245b59-d4b9-4ade-88b2-dbc1349fc8d5.png)
A complete backup of fundacion-canna.es
Are you over 18 and want to see adult content?
![A complete backup of futsalplanet.com](https://www.archivebay.com/archive5/images/34b341c2-384a-4fac-8492-9b771ff41131.png)
A complete backup of futsalplanet.com
Are you over 18 and want to see adult content?
![A complete backup of meshcomputers.com](https://www.archivebay.com/archive5/images/681836f6-c7b5-43fe-b618-99cc0d07aa13.png)
A complete backup of meshcomputers.com
Are you over 18 and want to see adult content?
![A complete backup of vitotechnology.com](https://www.archivebay.com/archive5/images/f1d61f13-11af-4ba4-967d-c5b4c50b89bd.png)
A complete backup of vitotechnology.com
Are you over 18 and want to see adult content?
![A complete backup of hottubcinema.com](https://www.archivebay.com/archive5/images/398bca9c-03b3-4502-9657-807bdbab1bfe.png)
A complete backup of hottubcinema.com
Are you over 18 and want to see adult content?
![A complete backup of onlynewsgroups.net](https://www.archivebay.com/archive5/images/0694fbab-edc7-4970-82af-213146ecf4e8.png)
A complete backup of onlynewsgroups.net
Are you over 18 and want to see adult content?
![A complete backup of alchemy-works.com](https://www.archivebay.com/archive5/images/ca721d69-cc2e-43bd-adca-616e1e56729c.png)
A complete backup of alchemy-works.com
Are you over 18 and want to see adult content?
Favourite Annotations
![A complete backup of rentacar-byala.com](https://www.archivebay.com/archive/7a2d2e40-bae5-4eeb-808c-aac552d269f5.png)
A complete backup of rentacar-byala.com
Are you over 18 and want to see adult content?
![A complete backup of babyandtoddlertown.com.au](https://www.archivebay.com/archive/77cf6629-8e6f-4814-878a-2086f9772ae4.png)
A complete backup of babyandtoddlertown.com.au
Are you over 18 and want to see adult content?
![A complete backup of toffisama.wordpress.com](https://www.archivebay.com/archive/082dc907-d12a-45ab-a3f2-cfd780d28ff6.png)
A complete backup of toffisama.wordpress.com
Are you over 18 and want to see adult content?
![A complete backup of kionkim.github.io](https://www.archivebay.com/archive/705d4fee-6b17-4cf7-ae27-9215ce0d82eb.png)
A complete backup of kionkim.github.io
Are you over 18 and want to see adult content?
![A complete backup of textbook-download.tokyo](https://www.archivebay.com/archive/19bb4ccd-f569-4927-af57-2406ff217c91.png)
A complete backup of textbook-download.tokyo
Are you over 18 and want to see adult content?
Text
JOB OPENINGS
Job openings - Setting a new standard for the future of pharma. JOB OPENINGS. The color of the sun. Like the sun, the Alvogen culture is a fusion of unity and strength – a culture that radiates optimism, personal responsibility and professional dedication. A culture caring about our customers, communities and each other, and this is reflectedLATEST NEWS
14 January 2020. Alvotech and JAMP Pharma enter into an exclusive partnership for the commercialization of key biosimilars in Canada. Business. 25 November 2019. Alvogen and Yas Holding announce license and distribution agreement to commercialize generics portfolio in MENA Region. Business. 13 November 2019. Alvogen at CPhI 2019. USA - SETTING A NEW STANDARD FOR THE FUTURE OF PHARMA 44 Whippany Road, Suite 300. Morristown, NJ 07960. Phone: 973.796.3400. High value generics. Alvogen product portfolio is focued on complex high value generics and brands, including; niche generics, patches, controlled release and narcotics. The company currently has over 75 ANDA's in its pipeline and 28 first-to-file opportunities.BRAND PROMISE
At Alvogen, we place great emphasis on our brand promise. Being the preferred partner and set a new standard for the future of pharma with commitment to: Best people, Best portfolio, Best service, Best quality and Cost efficiency. This is our promise to each and every one of our customers. The brand promise describes our commitment to continuously make a meaningful difference in the lives ofMEET OUR CEO
Alvogen is a global, privately owned pharmaceutical company focused on developing, manufacturing and selling generic, brand, over-the counter (OTC) and biosimilar products for patients around the world. With commercial footprint in over 20 markets, Alvogen’s key regions include the U.S. and APAC regions.LEADERSHIP TEAM
Alvogen’s leadership team is dedicated to fostering a dynamic change-driven culture committed to meeting the needs of our customers. Our organizational structure is lean and flexible, driving quick and effective decision making and thus enabling the company to bring new generic products quickly and safely to market. The executive leadership team forms the Alvogen Management Board.MEET OUR MANAGEMENT
Meet our management. Alvogen’s leadership team is dedicated to fostering a dynamic change-driven culture committed to meeting the needs of our customers. Our organizational structure is lean and flexible, driving quick and effective decision making and thus enabling the company to bring new generic products quickly and safelyto market. The
COMPLIANCE & ETHICS
Compliance & ethics. Alvogen’s Global Compliance & Ethics Program (the Program) is founded on the Company’s desire to conduct business in a legal and responsible manner with a commitment to compliance and ethics. We are intent on consistently demonstrating this commitment and being a trusted and respected Company. ALVOGEN AND ALVOTECH LAUNCH NEW B2B BUSINESS BRAND Alvogen is a global, privately owned pharmaceutical company focused on developing, manufacturing and selling generic, brand, over-the counter (OTC) and biosimilar products for patients around the world. With commercial footprint in over 20 markets, Alvogen’s key regions include the U.S. and APAC regions. ALVOGEN COMPLETES SALE OF ITS CENTRAL AND EASTERN EUROPEAN Alvogen announced today the completion of the sale of its Central and Eastern European (CEE) business to Zentiva for an undisclosed value. The sale of the company’s CEE platform includes over 200 generic and over-the-counter products across multiple therapeutic areas and covering 14 key markets. SETTING A NEW STANDARD FOR THE FUTURE OF PHARMACOMPANYDIVERSITY & INCLUSIONBRAND PROMISEHISTORYOUR VISIONCOMPLIANCE & ETHICS Alvogen is a global, privately owned pharmaceutical company focused on developing, manufacturing and selling generic, brand, over-the counter (OTC) and biosimilar products for patients around the world. With commercial footprint in over 20 markets, Alvogen’s key regions include the U.S. and APAC regions.JOB OPENINGS
Job openings - Setting a new standard for the future of pharma. JOB OPENINGS. The color of the sun. Like the sun, the Alvogen culture is a fusion of unity and strength – a culture that radiates optimism, personal responsibility and professional dedication. A culture caring about our customers, communities and each other, and this is reflectedLATEST NEWS
14 January 2020. Alvotech and JAMP Pharma enter into an exclusive partnership for the commercialization of key biosimilars in Canada. Business. 25 November 2019. Alvogen and Yas Holding announce license and distribution agreement to commercialize generics portfolio in MENA Region. Business. 13 November 2019. Alvogen at CPhI 2019. USA - SETTING A NEW STANDARD FOR THE FUTURE OF PHARMA 44 Whippany Road, Suite 300. Morristown, NJ 07960. Phone: 973.796.3400. High value generics. Alvogen product portfolio is focued on complex high value generics and brands, including; niche generics, patches, controlled release and narcotics. The company currently has over 75 ANDA's in its pipeline and 28 first-to-file opportunities.MEET OUR CEO
Alvogen is a global, privately owned pharmaceutical company focused on developing, manufacturing and selling generic, brand, over-the counter (OTC) and biosimilar products for patients around the world. With commercial footprint in over 20 markets, Alvogen’s key regions include the U.S. and APAC regions.MEET OUR MANAGEMENT
Meet our management. Alvogen’s leadership team is dedicated to fostering a dynamic change-driven culture committed to meeting the needs of our customers. Our organizational structure is lean and flexible, driving quick and effective decision making and thus enabling the company to bring new generic products quickly and safelyto market. The
LEADERSHIP TEAM
Alvogen’s leadership team is dedicated to fostering a dynamic change-driven culture committed to meeting the needs of our customers. Our organizational structure is lean and flexible, driving quick and effective decision making and thus enabling the company to bring new generic products quickly and safely to market. The executive leadership team forms the Alvogen Management Board. ALVOGEN AND ALVOTECH LAUNCH NEW B2B BUSINESS BRAND Alvogen is a global, privately owned pharmaceutical company focused on developing, manufacturing and selling generic, brand, over-the counter (OTC) and biosimilar products for patients around the world. With commercial footprint in over 20 markets, Alvogen’s key regions include the U.S. and APAC regions. ALVOGEN AND LOTUS PHARMACEUTICALS MERGE ASIAN OPERATIONS Alvogen is a global, privately owned pharmaceutical company focused on developing, manufacturing and selling generic, brand, over-the counter (OTC) and biosimilar products for patients around the world. With commercial footprint in over 20 markets, Alvogen’s key regions include the U.S. and APAC regions.SR PROJECT MANAGER
Sr. PM will lead and drive projects from development, validation and launch activities for the U.S. or Region as applicable. The successful incumbent will use project management methodologies and best practices to deliver projects on time and within budget. The Senior Project Manager will be working in a fast paced and dynamic team environment handling a varied portfolio of high visibilityLATEST NEWS
14 January 2020. Alvotech and JAMP Pharma enter into an exclusive partnership for the commercialization of key biosimilars in Canada. Business. 25 November 2019. Alvogen and Yas Holding announce license and distribution agreement to commercialize generics portfolio in MENA Region. Business. 13 November 2019. Alvogen at CPhI 2019.PARTNERSHIPS
At Alvogen, we value partnerships and collaboration. Our future strategy relies heavily on our strategic selection of people and successful partnerships around the world. We are open for ideas. What we look for. We believe that by working together, we can discover,develop, and
BRAND PROMISE
At Alvogen, we place great emphasis on our brand promise. Being the preferred partner and set a new standard for the future of pharma with commitment to: Best people, Best portfolio, Best service, Best quality and Cost efficiency. This is our promise to each and every one of our customers. The brand promise describes our commitment to continuously make a meaningful difference in the lives ofCOMPLIANCE & ETHICS
Alvogen’s Global Compliance & Ethics Program (the Program) is founded on the Company’s desire to conduct business in a legal and responsible manner with a commitment to compliance and ethics. We are intent on consistently demonstrating this commitment and being a trusted and respected Company.DISULFIRAM TABLETS
Alvogen is a global, privately owned pharmaceutical company focused on developing, manufacturing and selling generic, brand, over-the counter (OTC) and biosimilar products for patients around the world. With commercial footprint in over 20 markets, Alvogen’s key regions include the U.S. and APAC regions.JOB OPENINGS
Job openings - Setting a new standard for the future of pharma. JOB OPENINGS. The color of the sun. Like the sun, the Alvogen culture is a fusion of unity and strength – a culture that radiates optimism, personal responsibility and professional dedication. A culture caring about our customers, communities and each other, and this is reflected ALVOGEN COMPLETES SALE OF ITS CENTRAL AND EASTERN EUROPEAN Alvogen is a global, privately owned pharmaceutical company focused on developing, manufacturing and selling generic, brand, over-the counter (OTC) and biosimilar products for patients around the world. With commercial footprint in over 20 markets, Alvogen’s key regions include the U.S. and APAC regions. ALVOGEN ANNOUNCES DIVESTMENT OF ITS CENTRAL AND EASTERN Alvogen is a global, privately owned pharmaceutical company focused on developing, manufacturing and selling generic, brand, over-the counter (OTC) and biosimilar products for patients around the world. With commercial footprint in over 20 markets, Alvogen’s key regions include the U.S. and APAC regions. ALVOGEN GLOBAL BUSINESS DEVELOPMENT LEADERS Alvogen is a global, privately owned pharmaceutical company focused on developing, manufacturing and selling generic, brand, over-the counter (OTC) and biosimilar products for patients around the world. With commercial footprint in over 20 markets, Alvogen’s key regions include the U.S. and APAC regions. VANCOMYCIN HYDROCHLORIDE FOR INJECTION, USP Alvogen is a global, privately owned pharmaceutical company focused on developing, manufacturing and selling generic, brand, over-the counter (OTC) and biosimilar products for patients around the world. With commercial footprint in over 20 markets, Alvogen’s key regions include the U.S. and APAC regions. SETTING A NEW STANDARD FOR THE FUTURE OF PHARMACOMPANYDIVERSITY & INCLUSIONBRAND PROMISEHISTORYOUR VISIONCOMPLIANCE & ETHICS Alvogen is a global, privately owned pharmaceutical company focused on developing, manufacturing and selling generic, brand, over-the counter (OTC) and biosimilar products for patients around the world. With commercial footprint in over 20 markets, Alvogen’s key regions include the U.S. and APAC regions.JOB OPENINGS
Job openings - Setting a new standard for the future of pharma. JOB OPENINGS. The color of the sun. Like the sun, the Alvogen culture is a fusion of unity and strength – a culture that radiates optimism, personal responsibility and professional dedication. A culture caring about our customers, communities and each other, and this is reflected FACILITIES - SETTING A NEW STANDARD FOR THE FUTURE OF PHARMA Alvogen‘s global operations includes four manufacturing facilities in the U.S., South Korea and Taiwan. Capabilities include finished dosage form manufacturing including solid oral dosage, soft gelatin capsules, modified release tablets, transdermals, creams, ointments and injectables. The company also has biosimilar capabilities via its sister company, Alvotech, in a state-of-the-artMEET OUR CEO
Alvogen is a global, privately owned pharmaceutical company focused on developing, manufacturing and selling generic, brand, over-the counter (OTC) and biosimilar products for patients around the world. With commercial footprint in over 20 markets, Alvogen’s key regions include the U.S. and APAC regions. USA - SETTING A NEW STANDARD FOR THE FUTURE OF PHARMA 44 Whippany Road, Suite 300. Morristown, NJ 07960. Phone: 973.796.3400. High value generics. Alvogen product portfolio is focued on complex high value generics and brands, including; niche generics, patches, controlled release and narcotics. The company currently has over 75 ANDA's in its pipeline and 28 first-to-file opportunities.MEET OUR MANAGEMENT
Meet our management. Alvogen’s leadership team is dedicated to fostering a dynamic change-driven culture committed to meeting the needs of our customers. Our organizational structure is lean and flexible, driving quick and effective decision making and thus enabling the company to bring new generic products quickly and safelyto market. The
ALVOGEN AND ALVOTECH LAUNCH NEW B2B BUSINESS BRAND Alvogen is a global, privately owned pharmaceutical company focused on developing, manufacturing and selling generic, brand, over-the counter (OTC) and biosimilar products for patients around the world. With commercial footprint in over 20 markets, Alvogen’s key regions include the U.S. and APAC regions. ALVOGEN ANNOUNCES DIVESTMENT OF ITS CENTRAL AND EASTERN Alvogen is a global, privately owned pharmaceutical company focused on developing, manufacturing and selling generic, brand, over-the counter (OTC) and biosimilar products for patients around the world. With commercial footprint in over 20 markets, Alvogen’s key regions include the U.S. and APAC regions. ALVOGEN COMPLETES SALE OF ITS CENTRAL AND EASTERN EUROPEAN Alvogen announced today the completion of the sale of its Central and Eastern European (CEE) business to Zentiva for an undisclosed value. The sale of the company’s CEE platform includes over 200 generic and over-the-counter products across multiple therapeutic areas and covering 14 key markets. ALVOGEN AND LOTUS PHARMACEUTICALS MERGE ASIAN OPERATIONS Alvogen is a global, privately owned pharmaceutical company focused on developing, manufacturing and selling generic, brand, over-the counter (OTC) and biosimilar products for patients around the world. With commercial footprint in over 20 markets, Alvogen’s key regions include the U.S. and APAC regions.JOB OPENINGS
Job openings - Setting a new standard for the future of pharma. JOB OPENINGS. The color of the sun. Like the sun, the Alvogen culture is a fusion of unity and strength – a culture that radiates optimism, personal responsibility and professional dedication. A culture caring about our customers, communities and each other, and this is reflected FACILITIES - SETTING A NEW STANDARD FOR THE FUTURE OF PHARMA Alvogen‘s global operations includes four manufacturing facilities in the U.S., South Korea and Taiwan. Capabilities include finished dosage form manufacturing including solid oral dosage, soft gelatin capsules, modified release tablets, transdermals, creams, ointments and injectables. The company also has biosimilar capabilities via its sister company, Alvotech, in a state-of-the-artMEET OUR CEO
Alvogen is a global, privately owned pharmaceutical company focused on developing, manufacturing and selling generic, brand, over-the counter (OTC) and biosimilar products for patients around the world. With commercial footprint in over 20 markets, Alvogen’s key regions include the U.S. and APAC regions.MEET OUR MANAGEMENT
Meet our management. Alvogen’s leadership team is dedicated to fostering a dynamic change-driven culture committed to meeting the needs of our customers. Our organizational structure is lean and flexible, driving quick and effective decision making and thus enabling the company to bring new generic products quickly and safelyto market. The
USA - SETTING A NEW STANDARD FOR THE FUTURE OF PHARMA 44 Whippany Road, Suite 300. Morristown, NJ 07960. Phone: 973.796.3400. High value generics. Alvogen product portfolio is focued on complex high value generics and brands, including; niche generics, patches, controlled release and narcotics. The company currently has over 75 ANDA's in its pipeline and 28 first-to-file opportunities.BRAND PROMISE
At Alvogen, we place great emphasis on our brand promise. Being the preferred partner and set a new standard for the future of pharma with commitment to: Best people, Best portfolio, Best service, Best quality and Cost efficiency. This is our promise to each and every one of our customers. The brand promise describes our commitment to continuously make a meaningful difference in the lives ofCOMPLIANCE & ETHICS
Compliance & ethics. Alvogen’s Global Compliance & Ethics Program (the Program) is founded on the Company’s desire to conduct business in a legal and responsible manner with a commitment to compliance and ethics. We are intent on consistently demonstrating this commitment and being a trusted and respected Company. ALVOGEN AND ALVOTECH LAUNCH NEW B2B BUSINESS BRAND Alvogen is a global, privately owned pharmaceutical company focused on developing, manufacturing and selling generic, brand, over-the counter (OTC) and biosimilar products for patients around the world. With commercial footprint in over 20 markets, Alvogen’s key regions include the U.S. and APAC regions. ALVOGEN ANNOUNCES DIVESTMENT OF ITS CENTRAL AND EASTERN Alvogen is a global, privately owned pharmaceutical company focused on developing, manufacturing and selling generic, brand, over-the counter (OTC) and biosimilar products for patients around the world. With commercial footprint in over 20 markets, Alvogen’s key regions include the U.S. and APAC regions. ALVOGEN COMPLETES SALE OF ITS CENTRAL AND EASTERN EUROPEAN Alvogen announced today the completion of the sale of its Central and Eastern European (CEE) business to Zentiva for an undisclosed value. The sale of the company’s CEE platform includes over 200 generic and over-the-counter products across multiple therapeutic areas and covering 14 key markets.BRAND PROMISE
At Alvogen, we place great emphasis on our brand promise. Being the preferred partner and set a new standard for the future of pharma with commitment to: Best people, Best portfolio, Best service, Best quality and Cost efficiency. This is our promise to each and every one of our customers. The brand promise describes our commitment to continuously make a meaningful difference in the lives of ALVOGEN ANNOUNCES DIVESTMENT OF ITS CENTRAL AND EASTERN Alvogen is a global, privately owned pharmaceutical company focused on developing, manufacturing and selling generic, brand, over-the counter (OTC) and biosimilar products for patients around the world. With commercial footprint in over 20 markets, Alvogen’s key regions include the U.S. and APAC regions. ALVOGEN COMPLETES SALE OF ITS CENTRAL AND EASTERN EUROPEAN Alvogen is a global, privately owned pharmaceutical company focused on developing, manufacturing and selling generic, brand, over-the counter (OTC) and biosimilar products for patients around the world. With commercial footprint in over 20 markets, Alvogen’s key regions include the U.S. and APAC regions.PATIENT SAFETY
Patient safety. Pharmacovigilance is the process of collecting, monitoring, researching and evaluating information from healthcare providers and patients for the purposes of understanding and preventing drug-related problems. Alvogenʼs Global Quality Team is dedicated to the collection, monitoring, evaluation and reporting ofsafety
STORIES FROM LOCAL COMMUNITIES Once a year we hold the Alvogen Day of Service, where our colleagues around the world reach out to their local communities by providingsupport.
DISULFIRAM TABLETS
Alvogen is a global, privately owned pharmaceutical company focused on developing, manufacturing and selling generic, brand, over-the counter (OTC) and biosimilar products for patients around the world. With commercial footprint in over 20 markets, Alvogen’s key regions include the U.S. and APAC regions.TERMS OF USE
The trademarks, service marks and trade names shown in this Internet site are protected and cannot be used without prior written authorization from ALVOGEN. ALVOGEN may make changes to the information on this Internet site at any time, without prior notice. The company makes no commitment to update this information. Any legalclaims arising
FLUOCINONIDE GEL
Alvogen is a global, privately owned pharmaceutical company focused on developing, manufacturing and selling generic, brand, over-the counter (OTC) and biosimilar products for patients around the world. With commercial footprint in over 20 markets, Alvogen’s key regions include the U.S. and APAC regions. ALVOGEN RECEIVES APPROVAL OF QSYMIA® IN THE REPUBLIC OF Alvogen is a global, privately owned pharmaceutical company focused on developing, manufacturing and selling generic, brand, over-the counter (OTC) and biosimilar products for patients around the world. With commercial footprint in over 20 markets, Alvogen’s key regions include the U.S. and APAC regions.ANDREA SWEET
As head of Legal for the US, Andrea directs legal strategy for the US business and provides legal guidance to all departments. She leads Alvogen’s Hatch Waxman litigation strategy and also handles US transactions including acquisitions and partnerships. Prior to joining Alvogen, Andrea served as Director, Intellectual Property at Actavis. SETTING A NEW STANDARD FOR THE FUTURE OF PHARMACOMPANYDIVERSITY & INCLUSIONBRAND PROMISEHISTORYOUR VISIONCOMPLIANCE & ETHICS Alvogen is a global, privately owned pharmaceutical company focused on developing, manufacturing and selling generic, brand, over-the counter (OTC) and biosimilar products for patients around the world. With commercial footprint in over 20 markets, Alvogen’s key regions include the U.S. and APAC regions.JOB OPENINGS
Job openings - Setting a new standard for the future of pharma. JOB OPENINGS. The color of the sun. Like the sun, the Alvogen culture is a fusion of unity and strength – a culture that radiates optimism, personal responsibility and professional dedication. A culture caring about our customers, communities and each other, and this is reflected FACILITIES - SETTING A NEW STANDARD FOR THE FUTURE OF PHARMA Alvogen‘s global operations includes four manufacturing facilities in the U.S., South Korea and Taiwan. Capabilities include finished dosage form manufacturing including solid oral dosage, soft gelatin capsules, modified release tablets, transdermals, creams, ointments and injectables. The company also has biosimilar capabilities via its sister company, Alvotech, in a state-of-the-artMEET OUR CEO
Alvogen is a global, privately owned pharmaceutical company focused on developing, manufacturing and selling generic, brand, over-the counter (OTC) and biosimilar products for patients around the world. With commercial footprint in over 20 markets, Alvogen’s key regions include the U.S. and APAC regions. USA - SETTING A NEW STANDARD FOR THE FUTURE OF PHARMA 44 Whippany Road, Suite 300. Morristown, NJ 07960. Phone: 973.796.3400. High value generics. Alvogen product portfolio is focued on complex high value generics and brands, including; niche generics, patches, controlled release and narcotics. The company currently has over 75 ANDA's in its pipeline and 28 first-to-file opportunities.MEET OUR MANAGEMENT
Meet our management. Alvogen’s leadership team is dedicated to fostering a dynamic change-driven culture committed to meeting the needs of our customers. Our organizational structure is lean and flexible, driving quick and effective decision making and thus enabling the company to bring new generic products quickly and safelyto market. The
ALVOGEN AND ALVOTECH LAUNCH NEW B2B BUSINESS BRAND Alvogen is a global, privately owned pharmaceutical company focused on developing, manufacturing and selling generic, brand, over-the counter (OTC) and biosimilar products for patients around the world. With commercial footprint in over 20 markets, Alvogen’s key regions include the U.S. and APAC regions. ALVOGEN ANNOUNCES DIVESTMENT OF ITS CENTRAL AND EASTERN Alvogen is a global, privately owned pharmaceutical company focused on developing, manufacturing and selling generic, brand, over-the counter (OTC) and biosimilar products for patients around the world. With commercial footprint in over 20 markets, Alvogen’s key regions include the U.S. and APAC regions. ALVOGEN COMPLETES SALE OF ITS CENTRAL AND EASTERN EUROPEAN Alvogen announced today the completion of the sale of its Central and Eastern European (CEE) business to Zentiva for an undisclosed value. The sale of the company’s CEE platform includes over 200 generic and over-the-counter products across multiple therapeutic areas and covering 14 key markets. ALVOGEN AND LOTUS PHARMACEUTICALS MERGE ASIAN OPERATIONS Alvogen is a global, privately owned pharmaceutical company focused on developing, manufacturing and selling generic, brand, over-the counter (OTC) and biosimilar products for patients around the world. With commercial footprint in over 20 markets, Alvogen’s key regions include the U.S. and APAC regions. SETTING A NEW STANDARD FOR THE FUTURE OF PHARMACOMPANYDIVERSITY & INCLUSIONBRAND PROMISEHISTORYOUR VISIONCOMPLIANCE & ETHICS Alvogen is a global, privately owned pharmaceutical company focused on developing, manufacturing and selling generic, brand, over-the counter (OTC) and biosimilar products for patients around the world. With commercial footprint in over 20 markets, Alvogen’s key regions include the U.S. and APAC regions.JOB OPENINGS
Job openings - Setting a new standard for the future of pharma. JOB OPENINGS. The color of the sun. Like the sun, the Alvogen culture is a fusion of unity and strength – a culture that radiates optimism, personal responsibility and professional dedication. A culture caring about our customers, communities and each other, and this is reflected FACILITIES - SETTING A NEW STANDARD FOR THE FUTURE OF PHARMA Alvogen‘s global operations includes four manufacturing facilities in the U.S., South Korea and Taiwan. Capabilities include finished dosage form manufacturing including solid oral dosage, soft gelatin capsules, modified release tablets, transdermals, creams, ointments and injectables. The company also has biosimilar capabilities via its sister company, Alvotech, in a state-of-the-artMEET OUR CEO
Alvogen is a global, privately owned pharmaceutical company focused on developing, manufacturing and selling generic, brand, over-the counter (OTC) and biosimilar products for patients around the world. With commercial footprint in over 20 markets, Alvogen’s key regions include the U.S. and APAC regions. USA - SETTING A NEW STANDARD FOR THE FUTURE OF PHARMA 44 Whippany Road, Suite 300. Morristown, NJ 07960. Phone: 973.796.3400. High value generics. Alvogen product portfolio is focued on complex high value generics and brands, including; niche generics, patches, controlled release and narcotics. The company currently has over 75 ANDA's in its pipeline and 28 first-to-file opportunities.MEET OUR MANAGEMENT
Meet our management. Alvogen’s leadership team is dedicated to fostering a dynamic change-driven culture committed to meeting the needs of our customers. Our organizational structure is lean and flexible, driving quick and effective decision making and thus enabling the company to bring new generic products quickly and safelyto market. The
ALVOGEN AND ALVOTECH LAUNCH NEW B2B BUSINESS BRAND Alvogen is a global, privately owned pharmaceutical company focused on developing, manufacturing and selling generic, brand, over-the counter (OTC) and biosimilar products for patients around the world. With commercial footprint in over 20 markets, Alvogen’s key regions include the U.S. and APAC regions. ALVOGEN ANNOUNCES DIVESTMENT OF ITS CENTRAL AND EASTERN Alvogen is a global, privately owned pharmaceutical company focused on developing, manufacturing and selling generic, brand, over-the counter (OTC) and biosimilar products for patients around the world. With commercial footprint in over 20 markets, Alvogen’s key regions include the U.S. and APAC regions. ALVOGEN COMPLETES SALE OF ITS CENTRAL AND EASTERN EUROPEAN Alvogen announced today the completion of the sale of its Central and Eastern European (CEE) business to Zentiva for an undisclosed value. The sale of the company’s CEE platform includes over 200 generic and over-the-counter products across multiple therapeutic areas and covering 14 key markets. ALVOGEN AND LOTUS PHARMACEUTICALS MERGE ASIAN OPERATIONS Alvogen is a global, privately owned pharmaceutical company focused on developing, manufacturing and selling generic, brand, over-the counter (OTC) and biosimilar products for patients around the world. With commercial footprint in over 20 markets, Alvogen’s key regions include the U.S. and APAC regions. SETTING A NEW STANDARD FOR THE FUTURE OF PHARMA Alvogen is a global, privately owned pharmaceutical company focused on developing, manufacturing and selling generic, brand, over-the counter (OTC) and biosimilar products for patients around the world. With commercial footprint in over 20 markets, Alvogen’s key regions include the U.S. and APAC regions.BRAND PROMISE
At Alvogen, we place great emphasis on our brand promise. Being the preferred partner and set a new standard for the future of pharma with commitment to: Best people, Best portfolio, Best service, Best quality and Cost efficiency. This is our promise to each and every one of our customers. The brand promise describes our commitment to continuously make a meaningful difference in the lives of ALVOGEN ANNOUNCES DIVESTMENT OF ITS CENTRAL AND EASTERN Alvogen is a global, privately owned pharmaceutical company focused on developing, manufacturing and selling generic, brand, over-the counter (OTC) and biosimilar products for patients around the world. With commercial footprint in over 20 markets, Alvogen’s key regions include the U.S. and APAC regions.DISULFIRAM TABLETS
Alvogen is a global, privately owned pharmaceutical company focused on developing, manufacturing and selling generic, brand, over-the counter (OTC) and biosimilar products for patients around the world. With commercial footprint in over 20 markets, Alvogen’s key regions include the U.S. and APAC regions. ALVOGEN COMPLETES SALE OF ITS CENTRAL AND EASTERN EUROPEAN Alvogen is a global, privately owned pharmaceutical company focused on developing, manufacturing and selling generic, brand, over-the counter (OTC) and biosimilar products for patients around the world. With commercial footprint in over 20 markets, Alvogen’s key regions include the U.S. and APAC regions.FLUOCINONIDE GEL
Alvogen is a global, privately owned pharmaceutical company focused on developing, manufacturing and selling generic, brand, over-the counter (OTC) and biosimilar products for patients around the world. With commercial footprint in over 20 markets, Alvogen’s key regions include the U.S. and APAC regions. ALVOGEN RECEIVES APPROVAL OF QSYMIA® IN THE REPUBLIC OF Alvogen is a global, privately owned pharmaceutical company focused on developing, manufacturing and selling generic, brand, over-the counter (OTC) and biosimilar products for patients around the world. With commercial footprint in over 20 markets, Alvogen’s key regions include the U.S. and APAC regions.ANDREA SWEET
As head of Legal for the US, Andrea directs legal strategy for the US business and provides legal guidance to all departments. She leads Alvogen’s Hatch Waxman litigation strategy and also handles US transactions including acquisitions and partnerships. Prior to joining Alvogen, Andrea served as Director, Intellectual Property at Actavis.SR PROJECT MANAGER
Sr. PM will lead and drive projects from development, validation and launch activities for the U.S. or Region as applicable. The successful incumbent will use project management methodologies and best practices to deliver projects on time and within budget. The Senior Project Manager will be working in a fast paced and dynamic team environment handling a varied portfolio of high visibilityALVOGEN.COM
Redirecting to https://alvogen.com/ (308) THIS WEBSITE USES COOKIES We use cookies to personalise content and ads, to provide social media features and to analyse our traffic. We also share information about your use of our site with our social media, advertising and analytics partners who may combine it with other information that you’ve provided to them or that they’ve collected from your use of their services. You consent to our cookies if you continue to use ourwebsite.
Use necessary cookies only Allow all cookies Show detailsOK
Use necessary cookies only Allow selection Allow all cookiesNecessary
Preferences
Statistics
Marketing
Show details
Cookie declaration About cookies Necessary (4) Preferences (0) Statistics (4) Marketing (13) Unclassified (0) Necessary cookies help make a website usable by enabling basic functions like page navigation and access to secure areas of the website. The website cannot function properly without these cookies.NAME
PROVIDER
PURPOSE
EXPIRY
TYPE
CookieConsent
Cookiebot
Stores the user's cookie consent state for the current domain1 year
HTTP
rc::a
of their website.
Persistent
HTML
rc::c
Session
HTML
CONSENT
YouTube
Used to detect if the visitor has accepted the marketing category in the cookie banner. This cookie is necessary for GDPR-compliance of thewebsite.
6071 days
HTTP
Preference cookies enable a website to remember information that changes the way the website behaves or looks, like your preferred language or the region that you are in. We do not use cookies of this type. Statistic cookies help website owners to understand how visitors interact with websites by collecting and reporting informationanonymously.
NAME
PROVIDER
PURPOSE
EXPIRY
TYPE
_ga
2 years
HTTP
_gat
1 day
HTTP
_gid
1 day
HTTP
collect
Session
Pixel
Marketing cookies are used to track visitors across websites. The intention is to display ads that are relevant and engaging for the individual user and thereby more valuable for publishers and thirdparty advertisers.
NAME
PROVIDER
PURPOSE
EXPIRY
TYPE
IDE
to the user.
1 year
HTTP
test_cookie
1 day
HTTP
VISITOR_INFO1_LIVE
YouTube
Tries to estimate the users' bandwidth on pages with integratedYouTube videos.
179 days
HTTP
YSC
YouTube
Registers a unique ID to keep statistics of what videos from YouTubethe user has seen.
Session
HTTP
yt.innertube::nextIdYouTube
Registers a unique ID to keep statistics of what videos from YouTubethe user has seen.
Persistent
HTML
yt.innertube::requestsYouTube
Registers a unique ID to keep statistics of what videos from YouTubethe user has seen.
Persistent
HTML
yt-remote-cast-installedYouTube
Stores the user's video player preferences using embedded YouTubevideo
Session
HTML
yt-remote-connected-devicesYouTube
Stores the user's video player preferences using embedded YouTubevideo
Persistent
HTML
yt-remote-device-id
YouTube
Stores the user's video player preferences using embedded YouTubevideo
Persistent
HTML
yt-remote-fast-check-periodYouTube
Stores the user's video player preferences using embedded YouTubevideo
Session
HTML
yt-remote-session-appYouTube
Stores the user's video player preferences using embedded YouTubevideo
Session
HTML
yt-remote-session-nameYouTube
Stores the user's video player preferences using embedded YouTubevideo
Session
HTML
yt-remote-cast-availableYouTube
Pending
Session
HTML
Unclassified cookies are cookies that we are in the process of classifying, together with the providers of individual cookies. We do not use cookies of this type.Cookies are small text files that can be used by websites to make a user's experience more efficient. The law states that we can store cookies on your device if they are strictly necessary for the operation of this site. For all other types of cookies we need your permission. This site uses different types of cookies. Some cookies are placed by third party services that appear on our pages. You can at any time change or withdraw your consent from the Cookie Declaration on our website. Learn more about who we are, how you can contact us and how we process personal data in our Privacy Policy. Cookie declaration last updated on 5/18/21 by Cookiebot
Skip Navigation
*
01Company
Company
Diversity & inclusionBrand promise
History
Our vision
Compliance & ethics
Leadership team
Board of Directors
*
02Products
Products
Patient safety
Biosimiliars
Facilities
*
03Partnerships
Partnerships
Academic partnerships Events & ExhibitionsDossier licensing
*
04Purpose
Purpose
Citizenship
Culture
*
05Worldwide
Worldwide
APAC region
USA
Newsroom
Join us
Citizenship
Media gallery
Newsroom Join us CitizenshipMedia gallery
CompanyProductsPartnershipsPurposeWorldwideCompany
Diversity & inclusionBrand promise
History
Our vision
Compliance & ethics
Leadership team
Board of Directors
Products
Patient safety
Biosimiliars
Facilities
Partnerships
Academic partnerships Events & ExhibitionsDossier licensing
Purpose
Citizenship
Culture
Worldwide
APAC region
USA
Skip Navigation
Alvogen
Setting a new standard for the future of pharmaLATEST NEWS
*
*
*
*
PTT invests in Lotus*
Alvogen and sister company Alvotech donate 100 thousand US dollars to UNICEF in combat against COVID-19*
Frontline warrior against COVID-19*
*
*
Company
WHO WE ARE
Alvogen is a global, privately owned pharmaceutical company focused on developing, manufacturing and selling generic, brand, over-the counter (OTC) and biosimilar products for patients around the world. With commercial footprint in over 20 markets, Alvogen’s key regions include the U.S. and APAC regions.About us
Products
TARGETED PORTFOLIO
Alvogen's product portfolio consists of a broad range of leading molecules for the treatment of conditions in the areas of oncology, cardiology, respiratory, neurology and gastroenterology, in addition to a fast-growing portfolio of biosimilars, brands and OTC products.Our Products
Robert Wessman
MEET OUR CEO
Róbert Wessman‘s business plan for Alvogen was originally scribbled on a napkin in a New York restaurant back in 2009 in the middle of one of the worst financial crises in history when access to capital was virtually non-existent.Meet our CEO
Newsroom
LATEST NEWS AND INITIATIVES Follow news and programs from Alvogen around the world as they unfold.Business
PTT INVESTS IN LOTUSCharity
ALVOGEN AND SISTER COMPANY ALVOTECH DONATE 100 THOUSAND US DOLLARS TO UNICEF IN COMBAT AGAINST COVID-19Charity
FRONTLINE WARRIOR AGAINST COVID-19Purpose
MAKING A DIFFERENCE
Our true purpose as a company is to make people's lives better by producing high quality medicines that help people live longer, healthier and more active lives and making them more accessible to those who might not otherwise be able to afford them.Our purpose
Partnerships
OPEN FOR COLLABORATION At Alvogen, we value partnerships and collaboration. Our future strategy relies heavily on our strategic selection of people and successful partnerships around the world.Partnerships
Worldwide
WORLDWIDE OFFICES
Alvogen has commercial operations in 20 countries, with regional hubs, manufacturing and R&D capabilities in the U.S. and South Korea.Discover offices
* Company
* Products
* Partnerships
* Purpose
* Worldwide
* Citizenship
* Leadership team
* Contact us
* History
* Newsroom
* Media Gallery
*
*
*
* Terms of Use
* Privacy Policy
* Cookie Policy
* © 2020 Alvogen. All Rights ReservedDetails
Copyright © 2024 ArchiveBay.com. All rights reserved. Terms of Use | Privacy Policy | DMCA | 2021 | Feedback | Advertising | RSS 2.0